Welcome back to another episode of Talking Gut! Today, we’re joined once again by the legendary Professor Doug Drossman, a pioneer in the field of disorders of gut-brain interaction (DGBI), such as IBS. You may remember Dr. Drossman from Episode 13, where we explored the biopsychosocial model of care, and Episode 18, where we discussed communication strategies to strengthen the provider–patient relationship.

In this episode, we shift focus to neuromodulators medications that can play a key role in managing symptoms of DGBI. Dr. Drossman helps us unpack what these medications are, how they work, the science behind their use, and why they’re often misunderstood. We also talk about their role in treating both pain and motility symptoms, their impact on mood and gut function, and how they can be tailored to each patient’s needs.

Whether you're a patient exploring treatment options or a clinician looking to enhance your knowledge and confidence in prescribing these therapies, this conversation offers a wealth of evidence-based insight, practical guidance, and empathy. Dr. Drossman’s vast experience from his research and clinical work to his leadership in education and training makes this a rich and informative discussion.

So whether you're new to the world of neuromodulators or seeking a deeper understanding, we hope you enjoy this enlightening and empowering episode with Dr. Doug Drossman.